标题
Engineering CAR T Cells to Target the HIV Reservoir
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-08-13
DOI
10.3389/fcimb.2020.00410
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
- (2020) Julia Bergild McBrien et al. NATURE
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
- (2020) Amina Ait-Ammar et al. Frontiers in Microbiology
- Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
- (2020) Sai Arun Batra et al. Cancer Immunology Research
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
- (2019) Chang-Yi Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
- (2019) Prasanta K. Dash et al. Nature Communications
- Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
- (2019) Jianxia Zhou et al. Protein & Cell
- Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
- (2019) Kim Anthony-Gonda et al. Science Translational Medicine
- Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations
- (2019) Judith Grau-Expósito et al. PLoS Pathogens
- Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
- (2019) Eytan Herzig et al. CELL
- Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells
- (2019) Deanna A. Kulpa et al. JOURNAL OF VIROLOGY
- Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy
- (2019) Marion Pardons et al. Cell Reports
- Microglial Cells: The Main HIV-1 Reservoir in the Brain
- (2019) Clementine Wallet et al. Frontiers in Cellular and Infection Microbiology
- T‐cell exhaustion in HIV infection
- (2019) Craig Fenwick et al. IMMUNOLOGICAL REVIEWS
- Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
- (2018) Youry Kim et al. Cell Host & Microbe
- Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with minimal immunogenicity
- (2018) Mustafa H. Ghanem et al. CYTOTHERAPY
- Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
- (2018) Bian Hu et al. HUMAN GENE THERAPY
- The role of latency reversal agents in the cure of HIV: A review of current data
- (2018) Kiandokht Bashiri et al. IMMUNOLOGY LETTERS
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
- (2018) Szu-Han Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
- (2018) So-Yon Lim et al. Science Translational Medicine
- CRISPR-Cas based antiviral strategies against HIV-1
- (2018) Gang Wang et al. VIRUS RESEARCH
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Chimeric antigen receptor T-cell approaches to HIV cure
- (2018) Anne-Sophie Kuhlmann et al. Current Opinion in HIV and AIDS
- Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS
- (2018) Anjie Zhen et al. PLoS Pathogens
- Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
- (2018) Genevieve Tyndale Clutton et al. Frontiers in Immunology
- Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
- (2018) Kumudhini Preethi Haran et al. Frontiers in Immunology
- The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
- (2018) Ana Stojanovic et al. Frontiers in Immunology
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus
- (2018) Maria Giovanna Desimio et al. Frontiers in Immunology
- Programming CAR-T cells to kill cancer
- (2018) Louai Labanieh et al. Nature Biomedical Engineering
- HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site
- (2018) Zhen Wang et al. JOURNAL OF VIROLOGY
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
- (2018) Yotam Bar-On et al. NATURE MEDICINE
- IL-15 regulates susceptibility of CD4+ T cells to HIV infection
- (2018) Lara Manganaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
- (2018) Wanghong Hu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients
- (2018) Thomas D. Zaikos et al. Cell Reports
- Chimeric antigen receptor engineered stem cells: a novel HIV therapy
- (2017) Anjie Zhen et al. Immunotherapy
- Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
- (2017) Nancie M. Archin et al. JOURNAL OF CLINICAL INVESTIGATION
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
- (2017) Amy L. Ellis-Connell et al. JOURNAL OF VIROLOGY
- Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
- (2017) Angela Tsai et al. JOURNAL OF VIROLOGY
- Fully human CD19-specific chimeric antigen receptors for T-cell therapy
- (2017) D Sommermeyer et al. LEUKEMIA
- Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
- (2017) Malika Hale et al. MOLECULAR THERAPY
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection
- (2017) Geetha H. Mylvaganam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV
- (2017) Mayra A. Carrillo et al. Translational Research
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- HIV-Specific CD8 + T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue
- (2017) Morgan A. Reuter et al. Cell Reports
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
- (2017) Matthew D. Marsden et al. PLoS Pathogens
- Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor
- (2017) Rachel S. Leibman et al. PLoS Pathogens
- Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
- (2017) Dongfang Liu et al. Protein & Cell
- Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
- (2016) Carolina Gutiérrez et al. AIDS
- CAR-T Cell Therapy for Lymphoma
- (2016) Carlos A. Ramos et al. Annual Review of Medicine
- Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals
- (2016) Amy E. Baxter et al. Cell Host & Microbe
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
- (2016) Jinghe Huang et al. IMMUNITY
- HIV-specific CD8+ T cells and HIV eradication
- (2016) R. Brad Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
- (2016) Marco Ruella et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies
- (2016) Ayub Ali et al. JOURNAL OF VIROLOGY
- A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells
- (2016) Rasmus Offersen et al. JOURNAL OF VIROLOGY
- Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4 + T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
- (2016) Bingfeng Liu et al. JOURNAL OF VIROLOGY
- CRISPR-mediated Activation of Latent HIV-1 Expression
- (2016) Prajit Limsirichai et al. MOLECULAR THERAPY
- CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
- (2016) Gang Wang et al. MOLECULAR THERAPY
- Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
- (2016) Erica N. Borducchi et al. NATURE
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- Defective proviruses rapidly accumulate during acute HIV-1 infection
- (2016) Katherine M Bruner et al. NATURE MEDICINE
- PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
- (2016) Riddhima Banga et al. NATURE MEDICINE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Shocking HIV out of hiding
- (2016) Thomas A. Rasmussen et al. Current Opinion in HIV and AIDS
- The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
- (2016) G. Clutton et al. Scientific Reports
- IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle
- (2016) Mayte Coiras et al. Cell Reports
- CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
- (2016) Zhen Wang et al. Cell Reports
- Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
- (2016) Matthew Pace et al. PLoS Pathogens
- Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus
- (2016) George J. Leslie et al. PLoS Pathogens
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Targeting the Brain Reservoirs: Toward an HIV Cure
- (2016) Céline Marban et al. Frontiers in Immunology
- HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
- (2016) Carolina Garrido et al. Frontiers in Immunology
- The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
- (2016) Victoria E. Walker-Sperling et al. EBioMedicine
- Erratum: Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
- (2016) Rafal Kaminski et al. Scientific Reports
- In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
- (2016) Jessica Brogdon et al. Scientific Reports
- Targeting NF-κB Signaling with Protein Kinase C Agonists As an Emerging Strategy for Combating HIV Latency
- (2015) Guochun Jiang et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Ectopic expression of anti-HIV-1 shRNAs protects CD8 + T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation
- (2015) Masakazu Kamata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
- (2015) Gregory M. Laird et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells
- (2015) Anjie Zhen et al. MOLECULAR THERAPY
- HIV reservoirs: what, where and how to target them
- (2015) Melissa J. Churchill et al. NATURE REVIEWS MICROBIOLOGY
- Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells
- (2015) Carolyn Rydyznski et al. Nature Communications
- Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism
- (2015) Laura Díaz et al. Scientific Reports
- An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
- (2015) Gilles Darcis et al. PLoS Pathogens
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
- (2014) Y. Xu et al. BLOOD
- Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders
- (2014) Dionna Williams et al. CURRENT HIV RESEARCH
- Advances in NKG2D ligand recognition and responses by NK cells
- (2014) Nina Le Bert et al. IMMUNOLOGY AND CELL BIOLOGY
- IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
- (2014) H J Pegram et al. LEUKEMIA
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
- (2014) Nicole A. Doria-Rose et al. NATURE
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
- (2014) Julian H. Elliott et al. PLoS Pathogens
- Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
- (2014) Richard Brad Jones et al. PLoS Pathogens
- T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection
- (2014) Marcus Buggert et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model
- (2013) P. M. Younan et al. BLOOD
- A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
- (2013) A. M. Spivak et al. CLINICAL INFECTIOUS DISEASES
- Hematopoietic stem cells for cancer immunotherapy
- (2013) Eric Gschweng et al. IMMUNOLOGICAL REVIEWS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem/Progenitor Cells in Humanized BLT Mice
- (2013) Gene-Errol E. Ringpis et al. PLoS One
- PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads
- (2013) Edward Seung et al. PLoS One
- Stem-Cell-Based Gene Therapy for HIV Infection
- (2013) Anjie Zhen et al. Viruses-Basel
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
- (2012) Y. Lévy et al. CLINICAL INFECTIOUS DISEASES
- Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production
- (2012) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice
- (2012) B. E. Palmer et al. JOURNAL OF IMMUNOLOGY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques
- (2012) Lia Vassena et al. PLoS Pathogens
- In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells
- (2012) Scott G. Kitchen et al. PLoS Pathogens
- Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
- (2011) Katherine A. Thompson et al. AMERICAN JOURNAL OF PATHOLOGY
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- Activation of NK Cells by ADCC Antibodies and HIV Disease Progression
- (2011) Amy W Chung et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection
- (2010) Gabriel Gras et al. Retrovirology
- The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
- (2010) SCIENCE
- A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model
- (2009) S. Shimizu et al. BLOOD
- HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing
- (2009) J. Richard et al. BLOOD
- A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
- (2009) Y. Zhao et al. JOURNAL OF IMMUNOLOGY
- The Utility of ADCC Responses in HIV Infection
- (2008) Amy Chung et al. CURRENT HIV RESEARCH
- Tumor cell recognition by the NK cell activating receptor NKG2D
- (2008) Yenan T. Bryceson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now